⌕
QuidelOrtho · QDEL · Nasdaq
Tenet 44 · Weak
Compare
$9.87−3.33%At closeTenet 44 · Weak
$9.87−0.34 (−3.33%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

QuidelOrtho (QDEL) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 1.9% in FY25, net margin −41.5%. Worth your attention in FY25: Share count (+58.0%) and Returns vs FCF (n/m). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▼1.9%
2,730.2
FY21→FY25CAGR +12.6%/yr
Net income ($M)▲44.8%
−1,131.8
one-off year: see footnoteCAGR —
Free cash flow ($M)▲26.0%
−83.0
FY21→FY25CAGR —
Diluted EPS▲45.4%
−16.69
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+58.0%

42.9mn → 67.8mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$188.2M

steady at 6.9% of revenue (−3.5% YoY).

Returns vs FCF
n/m

$0.0M returned vs $−83.0M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)2730.2Revenue−1456.0COGS1274.2Gross profit−186.2R&D−844.0SG&A−919.2Op income−212.6Tax & other−1131.8Net income

-41¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
806040200%sector median net margin ~3%FY21FY25

Over this window: gross 75.3% → 46.7%. Net margin -41.5% is below the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
2,593.22,730.22,782.92,997.83,266.01,698.6▼1.9%+12.6%
Cost of revenue
1,446.51,456.01,496.41,500.71,329.8420.3▼2.7%+36.4%
Gross profit
1,146.71,274.21,286.51,497.11,936.21,278.3▼1.0%−0.1%
Research & development
181.9186.2218.7245.0187.995.7▼14.9%+18.1%
Selling, general & admin
840.5844.0818.6790.3633.3239.6▲3.1%+37.0%
Total operating expenses
1,274.12,193.43,247.41,358.01,092.5372.3▼32.5%+55.8%
Operating incomefeeds ROC rank
−127.4−919.2−1,960.9139.1843.7906.0▲53.1%—
Other income, net
−208.6−188.5−170.6−168.2−107.8−5.7——
Pretax income
−336.0−1,107.7−2,131.5−29.1735.9900.3▲48.0%—
Income tax
33.224.1−79.5−19.0187.2196.1—−40.8%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−369.2−1,131.8−2,052.0−10.1548.7704.2▲44.8%—
Per share
Diluted EPSbuyback-sensitive
−5.44−16.69−30.54−0.159.5616.43▲45.4%—
Diluted shares (mn)
68.7067.8067.2066.8057.4042.90▲0.9%+12.1%
Margins
Gross margin22nd pct in Healthcare
44.2%46.7%46.2%49.9%59.3%75.3%▲0.4pp−28.6pp
Operating margin
−4.9%−33.7%−70.5%4.6%25.8%53.3%▲36.8pp−87.0pp
Net margin25th pct in Healthcare
−14.2%−41.5%−73.7%−0.3%16.8%41.5%▲32.3pp−82.9pp
† TTM = trailing four quarters through 2026-09-27.FY23 effective tax rate was 65% vs a 22% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was 4% vs a 22% norm for this window, likely a one-time item; see the filing.
CSV export is on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-19 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was QuidelOrtho's revenue last fiscal year?

QuidelOrtho reported revenue of $2,730.2M in fiscal 2025, down 1.9% from fiscal 2024.

What was QuidelOrtho's net income?

QuidelOrtho reported net income of −$1,131.8M in fiscal 2025, a net margin of −41.5%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.